All Relations between dopaminergic and dopamine

Publication Sentence Publish Date Extraction Date Species
Ja-Hyun Bai. Stress and the dopaminergic reward system. Experimental & molecular medicine. vol 52. issue 12. 2021-10-13. PMID:33257725. dopamine regulates reward-related behavior through the mesolimbic dopaminergic pathway. 2021-10-13 2023-08-13 Not clear
Ja-Hyun Bai. Stress and the dopaminergic reward system. Experimental & molecular medicine. vol 52. issue 12. 2021-10-13. PMID:33257725. stress affects dopamine levels and dopaminergic neuronal activity in the mesolimbic dopamine system. 2021-10-13 2023-08-13 Not clear
Osama Y Alshogran, Laith N Al-Eitan, Shoroq M Altawalbeh, Hatem A Ama. Association of DRD4 exon III and 5-HTTLPR VNTR genetic polymorphisms with psychiatric symptoms in hemodialysis patients. PloS one. vol 16. issue 3. 2021-10-13. PMID:33784353. given that the dopaminergic and serotonergic pathways are involved in the etiology of psychiatric disease, this study evaluated the genetic association of dopamine d4 receptor (drd4) and serotonin transporter (slc6a4) genes with psychiatric symptom susceptibility among hd patients. 2021-10-13 2023-08-13 Not clear
Abhishek Kumar Mishra, Anubhuti Dixi. Dopaminergic Axons: Key Recitalists in Parkinson's Disease. Neurochemical research. 2021-10-12. PMID:34637100. parkinson's disease (pd) is associated with dopamine depletion in the striatum owing to the selective and progressive loss of the nigrostriatal dopaminergic neurons, which results in motor dysfunction and secondary clinical manifestations. 2021-10-12 2023-08-13 Not clear
Abhishek Kumar Mishra, Anubhuti Dixi. Dopaminergic Axons: Key Recitalists in Parkinson's Disease. Neurochemical research. 2021-10-12. PMID:34637100. the dopamine level in the striatum is preserved because of the innervation of the substantia nigra (sn) dopaminergic neurons into it. 2021-10-12 2023-08-13 Not clear
Abhishek Kumar Mishra, Anubhuti Dixi. Dopaminergic Axons: Key Recitalists in Parkinson's Disease. Neurochemical research. 2021-10-12. PMID:34637100. several strategies have been devised to protect the degenerating dopaminergic neurons or to restore the dopamine levels for treating pd. 2021-10-12 2023-08-13 Not clear
G Pagano, S Molloy, P G Bain, E A Rabiner, K Ray Chaudhuri, D J Brooks, N Paves. Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [ Parkinsonism & related disorders. vol 90. 2021-10-11. PMID:34385007. impulse control disorders are associated with lower ventral striatum dopamine d3 receptor availability in parkinson's disease: a [ reduced postsynaptic d3 dopaminergic receptor availability has been reported in the ventral striatum of pathological gamblers without parkinson's disease (pd) and in patients with pd and impulse control disorders (icd). 2021-10-11 2023-08-13 Not clear
Banashree Chetia Phukan, Ankumoni Dutta, Satarupa Deb, Rubul Saikia, Muhammed Khairujjaman Mazumder, Rajib Paul, Pallab Bhattacharya, Rajat Sandhir, Anupom Bora. Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson's disease: involvement of anti-inflammatory response. Experimental brain research. 2021-10-11. PMID:34633467. although the etiology of parkinson's disease (pd) is poorly understood, studies in animal models revealed loss of dopamine and the dopaminergic neurons harbouring the neurotransmitter to be the principal cause behind this neuro-motor disorder. 2021-10-11 2023-08-13 mouse
Rachel A Crawford, Kate R Bowman, Brianna S Cagle, Jonathan A Door. In vitro inhibition of glutathione-S-transferase by dopamine and its metabolites, 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylacetic acid. Neurotoxicology. vol 86. 2021-10-08. PMID:34314733. dopal, dopamine, and the metabolite 3,4-dihydroxyphenylacetic acid (dopac), inhibited the activity of gst isolated from n27 dopaminergic cells at an ic 2021-10-08 2023-08-13 Not clear
Kai-Jie He, Yu-Ting Zhang, Shi-Zhuang Wei, Shu-Min Jiang, Lin Xu, Chao Ren, Fen Wan. Impact of Maternal Separation on Dopamine System and its Association with Parkinson's Disease. Neuromolecular medicine. vol 22. issue 3. 2021-10-07. PMID:31933131. an increasing number of studies has found that ms not only affects the function of the hypothalamic-pituitary-adrenal axis and hippocampal 5-hydroxytryptamine system, but also causes dysfunction of the central dopamine (da) system and increases the susceptibility of dopaminergic neurons to pathogenic factors of parkinson's disease (pd), for instance, 6-hydroxydopamine, thus impairing motor function. 2021-10-07 2023-08-13 Not clear
Michelle S Antunes, Fernando Vagner Lobo Ladd, Aliny Antunes Barbosa Lobo Ladd, Amanda Lopez Moreira, Silvana Peterini Boeira, Leandro Cattelan Souz. Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis. Metabolic brain disease. vol 36. issue 1. 2021-10-07. PMID:33057922. moreover, hesperidin treatment attenuated the loss of dopaminergic neurons (th+ cells) in the snpc and the depletion of dopamine (da) and its metabolities 3,4-dihydroxyphenylacetic acid (dopac) and homovanillic acid (hva) in the striatum of 6-ohda-lesioned mice. 2021-10-07 2023-08-13 mouse
Amir Arash Hassanlou, Shole Jamali, Kimia RayatSanati, Zahra Mousavi, Abbas Haghparas. Cannabidiol modulates the METH-induced conditioned place preference through D2-like dopamine receptors in the hippocampal CA1 region. Brain research bulletin. vol 172. 2021-10-07. PMID:33862125. cannabidiol (cbd) has been shown to reduce the effects of meth through different mechanisms such as increasing the ecs activity, regulating emotional memory in the ventral hippocampus through d2-like dopamine receptors, and decreasing the mesolimbic dopaminergic activity. 2021-10-07 2023-08-13 rat
Li Zuo, Chunfang Dai, Lilin Yi, Zhifang Don. 7,8-dihydroxyflavone ameliorates motor deficits via regulating autophagy in MPTP-induced mouse model of Parkinson's disease. Cell death discovery. vol 7. issue 1. 2021-10-06. PMID:34545064. parkinson's disease (pd) is a neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra and diminished dopamine content in the striatum. 2021-10-06 2023-08-13 mouse
Yingliang Xie, Peizhen Wang, Xiaoyan Cui, Lei Liu, Pengcheng Wang, Shimei Jing, Qi Liu, Yuting Wang, Shiqiang Wan. Dopaminergic neurons project to the nucleus accumbens regulates anxiety-like behaviors through dopamine D Behavioural brain research. vol 416. 2021-10-05. PMID:34419513. dopaminergic neurons project to the nucleus accumbens regulates anxiety-like behaviors through dopamine d dopamine (da) transmission is important in the regulation of mood and anxiety behaviors. 2021-10-05 2023-08-13 mouse
Guillermo Fernández, Favio Krapacher, Soledad Ferreras, Gonzalo Quassollo, Macarena Mariel Mari, María Victoria Pisano, Antonella Montemerlo, María Dolores Rubianes, Claudia Bregonzio, Carlos Arias, María Gabriela Paglin. Lack of Cdk5 activity is involved on Dopamine Transporter expression and function: Evidences from an animal model of Attention-Deficit Hyperactivity Disorder. Experimental neurology. vol 346. 2021-10-04. PMID:34537209. interestingly, dopaminergic neurotransmission is altered in these mice as they have an increased dopamine (da) content together with a low da turnover. 2021-10-04 2023-08-13 mouse
Anthony M Downs, Xueliang Fan, Radhika F Kadakia, Yuping Donsante, H A Jinnah, Ellen J Hes. Cell-intrinsic effects of TorsinA(ΔE) disrupt dopamine release in a mouse model of TOR1A dystonia. Neurobiology of disease. vol 155. 2021-10-02. PMID:33894367. because striatal cholinergic neurotransmission mediates dopamine release, it is not known if the dopamine release deficit is mediated indirectly by abnormal acetylcholine neurotransmission or if tor1a(Δe) acts directly within dopaminergic neurons to attenuate release. 2021-10-02 2023-08-13 mouse
Sara Dominguez, Eugene Varfolomeev, Robert Brendza, Kim Stark, Joy Tea, Jose Imperio, Hai Ngu, Timothy Earr, Oded Foreman, Joshua D Webster, Amy Easton, Domagoj Vucic, Baris Bingo. Genetic inactivation of RIP1 kinase does not ameliorate disease in a mouse model of ALS. Cell death and differentiation. vol 28. issue 3. 2021-10-01. PMID:32994544. on the other hand, genetic inactivation of rip1 kinase activity ameliorated the depletion of the neurotransmitter dopamine in a toxin model of dopaminergic neurodegeneration. 2021-10-01 2023-08-13 mouse
Adriano Lama, Claudio Pirozzi, Carmen Avagliano, Chiara Annunziata, Maria Pina Mollica, Antonio Calignano, Rosaria Meli, Giuseppina Mattace Ras. Nutraceuticals: An integrative approach to starve Parkinson's disease. Brain, behavior, & immunity - health. vol 2. 2021-10-01. PMID:34589828. current treatment approaches include mainly dopamine replacement therapy or optimizing dopaminergic transmission; however, these strategies that do not counteract the pathogenic mechanisms underlying pd symptoms and often are less effective over time. 2021-10-01 2023-08-13 Not clear
Taruna Pandey, Aparna Shukla, Mashu Trivedi, Feroz Khan, Rakesh Pande. Swertiamarin from Enicostemma littorale, counteracts PD associated neurotoxicity via enhancement α-synuclein suppressive genes and SKN-1/NRF-2 activation through MAPK pathway. Bioorganic chemistry. vol 108. 2021-09-30. PMID:33548732. the neuroprotective effect of sw was evident from the robust reduction of 6-hydroxydopamine (6-ohda) induced dopaminergic neurodegeneration independent of dopamine transporter (dat-1). 2021-09-30 2023-08-13 caenorhabditis_elegans
R A Nolan, K L Reeb, Y Rong, S M Matt, H S Johnson, K Runner, P J Gaskil. Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages. Brain, behavior, & immunity - health. vol 2. 2021-09-29. PMID:33665636. all addictive drugs modulate the dopaminergic system and our previous studies have identified dopamine as a pro-inflammatory modulator of macrophage function. 2021-09-29 2023-08-13 human